Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
Age
40–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, 40-75 yrs old,inclusive.
Rating of greater than or equal to 1 on the Goddard scale in assessment of emphysema severity by HRCT.
FEV1: FVC greater than 70% predicted.
At least 1 documented COPD exacerbation within the past year but not within 8 weeks of randomization.
Current or former smokers with a cigarette smoking history of at least 20 pack-years (or equivalent) and whose smoking status has not changed 60 days prior to screening.
You may not be if
Patients with asthma, active tuberculosis or bronchiectasis.
A respiratory tract infection within 30 days prior to the screening visit.
Any malignancy within the last 5 years with the exception of non-melanomatous skin cancer.
Uncontrolled cardiovascular, endocrine, blood, or nervous system disorders.
Uncontrolled condition with COPD exacerbation of level 2 or 3 in the 8-week period prior to randomization.
Systemic use of corticosteroids or other immunosuppressive agents within 30 days of the screening visit.
